Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

Hubei Hongyuan Pharmaceutical Technology Co Change In Receivables Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Change In Receivables		Get a 7-Day Free Trial					-142.15	-155.24	-289.98	-494.66	-152.75

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
	Jun15	Dec15	Jun16	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Hubei Hongyuan Pharmaceutical Technology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Hongyuan Pharmaceutical Technology Co  (SZSE:301246) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

2. In Ben Graham's calculation of liquidation value, Hubei Hongyuan Pharmaceutical Technology Co's accounts receivable are only considered to be worth 75% of book value:

Hubei Hongyuan Pharmaceutical Technology Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Hongyuan Pharmaceutical Technology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description